Healthy volunteers test new drug interactions
NCT ID NCT06942936
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 1 study tested how a new drug called AZD5004 interacts with the antifungal itraconazole and with birth control pills in 51 healthy volunteers. The goal was to measure how these drugs affect each other's levels in the body, not to treat any disease. Results will help guide future dosing and safety for people who may take AZD5004 along with these common medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AZD5004, itraconazole, and ethinyl estradiol/levonorgestrel (birth control pill)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Baltimore, Maryland, 21225, United States
-
Research Site
Berlin, 14050, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates